cysteine has been researched along with Supranuclear Palsy, Progressive in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Harigaya, Y; Hayashi, T; Kamiya, T; Kawarabayashi, T; Kurata, T; Manabe, Y; Miyazaki, K; Morimoto, N; Murakami, T; Nagai, M; Ohta, T; Ohta, Y; Shoji, M; Takao, Y; Takehisa, Y | 1 |
| Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kametaka, S; Kurata, T; Manabe, Y; Morimoto, N; Ohta, T; Ohta, Y; Sato, S; Takao, Y | 1 |
| Barbier, A; Colosimo, C; Daniele, A; Di Giuda, D; Fasano, A; Gainotti, G; Giordano, A; Piccininni, C; Spinelli, P; Tondo, G; Vita, MG | 1 |
| Amboni, M; Barone, P; De Michele, G; Filla, A; Nobili, F; Pagani, M; Pappatà , S; Salmaso, D; Salvatore, E; Salvatore, M; Sansone, V; Varrone, A | 1 |
| Ishida, R; Mizusawa, H; Murata, Y; Saitoh, Y; Shibuya, H; Zhang, L | 1 |
1 trial(s) available for cysteine and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET.
Topics: Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Nerve Degeneration; Organotechnetium Compounds; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2001 |
4 other study(ies) available for cysteine and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
Differentiation of PA from early PSP with different patterns of symptoms and CBF reduction.
Topics: Aged; Atrophy; Cerebrovascular Circulation; Cysteine; Dementia; Diagnosis, Differential; Eye Movements; Female; Frontal Lobe; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Movement Disorders; Muscle Rigidity; Nystagmus, Optokinetic; Organotechnetium Compounds; Radiography; Supranuclear Palsy, Progressive; Time Factors; Tomography, Emission-Computed, Single-Photon | 2008 |
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2011 |
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy.
Topics: Aged; Brain; Cerebrovascular Circulation; Comprehension; Cysteine; Decision Making; Female; Frontal Lobe; Functional Laterality; Humans; Image Processing, Computer-Assisted; Language; Male; Memory, Long-Term; Memory, Short-Term; Middle Aged; Neuroimaging; Neuropsychological Tests; Organotechnetium Compounds; Psycholinguistics; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Semantics; Supranuclear Palsy, Progressive; Verbal Behavior | 2013 |
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease.
Topics: Cysteine; Diagnosis, Differential; Female; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Organotechnetium Compounds; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2007 |